Some clusters of children with a multisystem inflammatory syndrome associated with SARS-CoV-2 infection (MIS-C) have been reported. We describe the epidemiological and clinical features of children with MIS-C in Spain. MIS-C is a potentially severe condition that presents in children with recent SARS-CoV-2 infection.
Background:
COVID-19 has reached more than 20 million people since its appearance in December 2019. As a result of the infection process by the Sars-CoV-2 virus, patients manifest initial symptoms easily mistaken for common flu. However, in a small group of the population, the condition may progress to pneumonia or Severe Acute Respiratory Syndrome (SARS).
Objective:
The objective of this study was to carry out an integrative review on laboratory and imaging diagnostics for COVID-19, in the period from 2019 to 2021.
Method:
Electronic databases PubMed, Google Scholar, SciELO, Virtual Library, LILACS, MEDLINE, ScienceDirect and the official website of the World Health Organization were used.
Results:
RT-qPCR identifies fragments of viral RNA in the initial stage of the disease since the genes E and RdRp are the most used, given the great sensitivity. Imaging and serological methods can be used as complementary exams. The main radiographic findings are reticular and ground-glass opacity patterns, reversed halo sign, mosaic attenuation, and consolidations. The antibody levels are detected after the seventh day of symptom onset.
Conclusion:
Caution should be exercised when interpreting the results for the diagnosis of COVID-19, since the onset of clinical symptoms and laboratory and imaging tests must be taken into account.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.